These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 16107831)

  • 1. Unscrambling hepatitis C virus-host interactions.
    Chisari FV
    Nature; 2005 Aug; 436(7053):930-2. PubMed ID: 16107831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects for a vaccine against the hepatitis C virus.
    Houghton M; Abrignani S
    Nature; 2005 Aug; 436(7053):961-6. PubMed ID: 16107836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-human primate surrogate model of hepatitis C virus infection.
    Akari H; Iwasaki Y; Yoshida T; Iijima S
    Microbiol Immunol; 2009 Jan; 53(1):53-7. PubMed ID: 19161559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evasion of intracellular host defence by hepatitis C virus.
    Gale M; Foy EM
    Nature; 2005 Aug; 436(7053):939-45. PubMed ID: 16107833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New therapeutic options for hepatitis C.
    Waters L; Nelson M
    Curr Opin Infect Dis; 2006 Dec; 19(6):615-22. PubMed ID: 17075339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C: virus, host, disease.
    Ippolito G; Craxi A
    Cell Death Differ; 2003 Jan; 10 Suppl 1():S1-2. PubMed ID: 12655335
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental models for hepatitis C viral infection.
    Boonstra A; van der Laan LJ; Vanwolleghem T; Janssen HL
    Hepatology; 2009 Nov; 50(5):1646-55. PubMed ID: 19670425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospects for prophylactic and therapeutic vaccines against hepatitis C virus.
    Feinstone SM; Hu DJ; Major ME
    Clin Infect Dis; 2012 Jul; 55 Suppl 1():S25-32. PubMed ID: 22715210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+ immune escape and subsequent T-cell failure following chimpanzee immunization against hepatitis C virus.
    Puig M; Mihalik K; Tilton JC; Williams O; Merchlinsky M; Connors M; Feinstone SM; Major ME
    Hepatology; 2006 Sep; 44(3):736-45. PubMed ID: 16941702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCV research and anti-HCV drug discovery: toward the next generation.
    Wakita T
    Adv Drug Deliv Rev; 2007 Oct; 59(12):1196-9. PubMed ID: 17905463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospects for hepatitis C vaccine.
    Zuckerman AJ; Zuckerman JN
    J Hepatol; 1995; 22(1 Suppl):97-100. PubMed ID: 7602087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent contributions of in vitro models to our understanding of hepatitis C virus life cycle.
    Régeard M; Lepère C; Trotard M; Gripon P; Le Seyec J
    FEBS J; 2007 Sep; 274(18):4705-18. PubMed ID: 17824957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems.
    Gottwein JM; Bukh J
    Adv Virus Res; 2008; 71():51-133. PubMed ID: 18585527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCV and interferon: viral strategies for evading innate defence mechanisms in the virus-host battle.
    Capobianchi MR; Abbate I; Cappiello G; Solmone M
    Cell Death Differ; 2003 Jan; 10 Suppl 1():S22-4. PubMed ID: 12655342
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathophysiology of hepatitis C virus infection.
    Camps J; Córdoba J; Esteban JI
    Pathol Biol (Paris); 1995 Oct; 43(8):691-702. PubMed ID: 8745591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subversion of innate host antiviral strategies by the hepatitis C virus.
    Bode JG; Brenndörfer ED; Häussinger D
    Arch Biochem Biophys; 2007 Jun; 462(2):254-65. PubMed ID: 17467654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular methods of hepatitis C genotyping.
    Weck K
    Expert Rev Mol Diagn; 2005 Jul; 5(4):507-20. PubMed ID: 16013969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment and vaccination for hepatitis C: present and future.
    Jawaid A; Khuwaja AK
    J Ayub Med Coll Abbottabad; 2008; 20(1):129-33. PubMed ID: 19024206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
    Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
    Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral interaction and clinical implications of coinfection of hepatitis C virus with other hepatitis viruses.
    Lin L; Verslype C; van Pelt JF; van Ranst M; Fevery J
    Eur J Gastroenterol Hepatol; 2006 Dec; 18(12):1311-9. PubMed ID: 17099381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.